Prostaglandin E2 increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: Regulation by interleukin-2, interleukin-10, and bovine leukemia virus

Dohun Pyeon, Francisco J. Diaz, Gary A. Splitter

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Prostaglandin E2 (PGE2), produced by macrophages, has important immune regulatory functions, suppressing a type 1 immune response and stimulating a type 2 immune response. Type 1 cytokines (interleukin-2 [IL-2], IL-12, and gamma interferon) increase in freshly isolated peripheral blood mononuclear cells (PBMCs) of animals with an early disease stage of bovine leukemia virus (BLV) infection, while IL-10 increases in animals with a late disease stage. Although IL-10 has an immunosuppressive role in the host immune system, IL-10 also inhibits BLV tax and pol mRNA levels in vitro. In contrast, IL-2 stimulates BLV tax and pol mRNA and p24 protein expression in cultured PBMCs. The inhibitory effect of IL-10 on BLV expression depends on soluble factors secreted by macrophages. Thus, we hypothesized that PGE2, a cyclooxygenase 2 (COX-2) product of macrophages, may regulate BLV expression. Here, we show that the level of COX-2 mRNA was decreased in PBMCs treated with IL-10, while IL-2 enhanced the level of COX-2 mRNA. Addition of PGE2 stimulated BLV tax and pol mRNA levels and reversed the IL-10 inhibition of BLV mRNA. In addition, the specific COX-2 inhibitor, NS-398, inhibited the amount of BLV mRNA detected. Addition of PGE2 increased BLV tax mRNA regardless of NS-398 addition. PGE2 inhibited antigen-specific PBMC stimulation, suggesting that stimulation of BLV tax and pol mRNA levels by PGE2 is independent of cell proliferation. These findings suggest that macrophage-derived COX-2 products, such as PGE2, regulate virus expression and disease progression in BLV infection.

Original languageEnglish (US)
Pages (from-to)5740-5745
Number of pages6
JournalJournal of virology
Volume74
Issue number12
DOIs
StatePublished - Jun 22 2000

Fingerprint

Bovine Leukemia Virus
Bovine leukemia virus
taxes
prostaglandin synthase
Cyclooxygenase 2
interleukin-10
interleukin-2
Dinoprostone
Interleukin-10
prostaglandins
Interleukin-2
Messenger RNA
mononuclear leukocytes
Blood Cells
macrophages
Virus Diseases
Macrophages
immune response
immunosuppressive agents
Cyclooxygenase 2 Inhibitors

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

@article{1878f9dff9a548918198cb44b69d7c00,
title = "Prostaglandin E2 increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: Regulation by interleukin-2, interleukin-10, and bovine leukemia virus",
abstract = "Prostaglandin E2 (PGE2), produced by macrophages, has important immune regulatory functions, suppressing a type 1 immune response and stimulating a type 2 immune response. Type 1 cytokines (interleukin-2 [IL-2], IL-12, and gamma interferon) increase in freshly isolated peripheral blood mononuclear cells (PBMCs) of animals with an early disease stage of bovine leukemia virus (BLV) infection, while IL-10 increases in animals with a late disease stage. Although IL-10 has an immunosuppressive role in the host immune system, IL-10 also inhibits BLV tax and pol mRNA levels in vitro. In contrast, IL-2 stimulates BLV tax and pol mRNA and p24 protein expression in cultured PBMCs. The inhibitory effect of IL-10 on BLV expression depends on soluble factors secreted by macrophages. Thus, we hypothesized that PGE2, a cyclooxygenase 2 (COX-2) product of macrophages, may regulate BLV expression. Here, we show that the level of COX-2 mRNA was decreased in PBMCs treated with IL-10, while IL-2 enhanced the level of COX-2 mRNA. Addition of PGE2 stimulated BLV tax and pol mRNA levels and reversed the IL-10 inhibition of BLV mRNA. In addition, the specific COX-2 inhibitor, NS-398, inhibited the amount of BLV mRNA detected. Addition of PGE2 increased BLV tax mRNA regardless of NS-398 addition. PGE2 inhibited antigen-specific PBMC stimulation, suggesting that stimulation of BLV tax and pol mRNA levels by PGE2 is independent of cell proliferation. These findings suggest that macrophage-derived COX-2 products, such as PGE2, regulate virus expression and disease progression in BLV infection.",
author = "Dohun Pyeon and Diaz, {Francisco J.} and Splitter, {Gary A.}",
year = "2000",
month = "6",
day = "22",
doi = "10.1128/JVI.74.12.5740-5745.2000",
language = "English (US)",
volume = "74",
pages = "5740--5745",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Prostaglandin E2 increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2

T2 - Regulation by interleukin-2, interleukin-10, and bovine leukemia virus

AU - Pyeon, Dohun

AU - Diaz, Francisco J.

AU - Splitter, Gary A.

PY - 2000/6/22

Y1 - 2000/6/22

N2 - Prostaglandin E2 (PGE2), produced by macrophages, has important immune regulatory functions, suppressing a type 1 immune response and stimulating a type 2 immune response. Type 1 cytokines (interleukin-2 [IL-2], IL-12, and gamma interferon) increase in freshly isolated peripheral blood mononuclear cells (PBMCs) of animals with an early disease stage of bovine leukemia virus (BLV) infection, while IL-10 increases in animals with a late disease stage. Although IL-10 has an immunosuppressive role in the host immune system, IL-10 also inhibits BLV tax and pol mRNA levels in vitro. In contrast, IL-2 stimulates BLV tax and pol mRNA and p24 protein expression in cultured PBMCs. The inhibitory effect of IL-10 on BLV expression depends on soluble factors secreted by macrophages. Thus, we hypothesized that PGE2, a cyclooxygenase 2 (COX-2) product of macrophages, may regulate BLV expression. Here, we show that the level of COX-2 mRNA was decreased in PBMCs treated with IL-10, while IL-2 enhanced the level of COX-2 mRNA. Addition of PGE2 stimulated BLV tax and pol mRNA levels and reversed the IL-10 inhibition of BLV mRNA. In addition, the specific COX-2 inhibitor, NS-398, inhibited the amount of BLV mRNA detected. Addition of PGE2 increased BLV tax mRNA regardless of NS-398 addition. PGE2 inhibited antigen-specific PBMC stimulation, suggesting that stimulation of BLV tax and pol mRNA levels by PGE2 is independent of cell proliferation. These findings suggest that macrophage-derived COX-2 products, such as PGE2, regulate virus expression and disease progression in BLV infection.

AB - Prostaglandin E2 (PGE2), produced by macrophages, has important immune regulatory functions, suppressing a type 1 immune response and stimulating a type 2 immune response. Type 1 cytokines (interleukin-2 [IL-2], IL-12, and gamma interferon) increase in freshly isolated peripheral blood mononuclear cells (PBMCs) of animals with an early disease stage of bovine leukemia virus (BLV) infection, while IL-10 increases in animals with a late disease stage. Although IL-10 has an immunosuppressive role in the host immune system, IL-10 also inhibits BLV tax and pol mRNA levels in vitro. In contrast, IL-2 stimulates BLV tax and pol mRNA and p24 protein expression in cultured PBMCs. The inhibitory effect of IL-10 on BLV expression depends on soluble factors secreted by macrophages. Thus, we hypothesized that PGE2, a cyclooxygenase 2 (COX-2) product of macrophages, may regulate BLV expression. Here, we show that the level of COX-2 mRNA was decreased in PBMCs treated with IL-10, while IL-2 enhanced the level of COX-2 mRNA. Addition of PGE2 stimulated BLV tax and pol mRNA levels and reversed the IL-10 inhibition of BLV mRNA. In addition, the specific COX-2 inhibitor, NS-398, inhibited the amount of BLV mRNA detected. Addition of PGE2 increased BLV tax mRNA regardless of NS-398 addition. PGE2 inhibited antigen-specific PBMC stimulation, suggesting that stimulation of BLV tax and pol mRNA levels by PGE2 is independent of cell proliferation. These findings suggest that macrophage-derived COX-2 products, such as PGE2, regulate virus expression and disease progression in BLV infection.

UR - http://www.scopus.com/inward/record.url?scp=0034117093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034117093&partnerID=8YFLogxK

U2 - 10.1128/JVI.74.12.5740-5745.2000

DO - 10.1128/JVI.74.12.5740-5745.2000

M3 - Article

C2 - 10823885

AN - SCOPUS:0034117093

VL - 74

SP - 5740

EP - 5745

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 12

ER -